UMP Healthcare Holdings Limited (HKG:0722)

UMP Healthcare Holdings Financials Overview

Financials in millions HKD. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	723.59	727.36	750.01	727.75	666.2	617.16
Revenue Growth	-0.52%	-3.02%	3.06%	9.24%	7.95%	10.44%
Gross Profit Gross Profit Growth	490.27	490.61	496.73	502.69	463.95	456.28
Operating Income Operating Income Growth	39.24	37.49	26.03	69.62	75.81	103.73
Net Income Net Income Growth	31.88	31.44	40.64	60.45	72.17	34.83
Earnings Per Share EPS Growth	0.04	0.04	0.05	0.08	0.09	0.05
EPS Growth	2.73%	-21.65%	-33.60%	-17.43%	102.38%	-41.01%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Hong Kong & Macau - Corporate Healthcare Solution Services Hong Kong & Macau - Corporate Healthcare Solution Services Growth	269.04	266.48	255.84	246.23	236.98	232.37
Hong Kong & Macau - Clinical Healthcare Services Hong Kong & Macau - Clinical Healthcare Services Growth	557.34	558.26	583.08	562.77	500.42	449.35
Mainland China - Clinical Healthcare Services Mainland China - Clinical Healthcare Services Growth	38.09	38.99	43.1	44.66	37.59	36.89
Elimination of Inter-Segment Sales Elimination of Inter-Segment Sales Growth	-141.26	-136.78	-133.54	-126.49	-109.13	-102.24
Total Total Growth	723.21	726.95	748.49	727.17	665.86	616.36

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	389.94	359.33	307.49	334.63	291.65	344.59
Total Debt Total Debt Growth	159.08	161.55	172.57	172.22	148.34	78.03
Net Cash (Debt) Net Cash Growth	230.86	197.78	134.92	162.41	143.31	266.56
Net Cash Growth	16.72%	46.59%	-16.93%	13.33%	-46.24%	39.92%
Net Cash Per Share Net Cash Per Share Growth	0.30	0.25	0.17	0.21	0.19	0.35

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	136.44	151.98	148.79	190.04	110.91	172.67
Capital Expenditures CapEx Growth	-22.48	-11.64	-57.25	-109.33	-84.52	-23.51
Free Cash Flow Free Cash Flow Growth	113.96	140.34	91.54	80.71	26.4	149.17
Free Cash Flow Growth	-18.80%	53.31%	13.42%	205.74%	-82.30%	44.59%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	67.75%	67.45%	66.23%	69.07%	69.64%	73.93%
Operating Margin	5.42%	5.16%	3.47%	9.57%	11.38%	16.81%
Pretax Margin	5.68%	5.57%	5.42%	8.84%	12.91%	14.64%
Profit Margin	4.41%	4.32%	5.42%	8.31%	10.83%	5.64%
FCF Margin	15.75%	19.29%	12.21%	11.09%	3.96%	24.17%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Dividend Per Share Dividend Per Share Growth	0.033	0.033	0.033	0.047	0.045	0.038
Dividend Per Share Growth	-2.94%	0%	-29.79%	4.44%	18.42%	15.15%
Dividend Yield	7.50%	7.37%	7.38%	7.65%	7.98%	5.74%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	10.76	12.21	10.23	10.20	8.13	20.47
Forward PE	-	19.24	19.24	19.24	19.24	19.24
P/FCF Ratio	3.10	2.74	4.54	7.64	22.24	4.78
PS Ratio	0.49	0.53	0.55	0.85	0.88	1.16

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 10, 2026

Data Sources Report a data error